Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4129965
Max Phase: Preclinical
Molecular Formula: C32H50IN3S
Molecular Weight: 508.84
Molecule Type: Small molecule
Associated Items:
ID: ALA4129965
Max Phase: Preclinical
Molecular Formula: C32H50IN3S
Molecular Weight: 508.84
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCCCCc1cc2nc3ccc(N(C)C)cc3sc-2cc1=[N+](C)C.[I-]
Standard InChI: InChI=1S/C32H50N3S.HI/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26-23-29-32(25-30(26)35(4)5)36-31-24-27(34(2)3)21-22-28(31)33-29;/h21-25H,6-20H2,1-5H3;1H/q+1;/p-1
Standard InChI Key: PQCSJALMHHZARC-UHFFFAOYSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 508.84 | Molecular Weight (Monoisotopic): 508.3720 | AlogP: 8.52 | #Rotatable Bonds: 16 |
Polar Surface Area: 19.14 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 3.12 | CX LogP: 6.44 | CX LogD: 6.44 |
Aromatic Rings: 1 | Heavy Atoms: 36 | QED Weighted: 0.11 | Np Likeness Score: -0.70 |
1. Khdour OM, Bandyopadhyay I, Chowdhury SR, Visavadiya NP, Hecht SM.. (2018) Lipophilic methylene blue analogues enhance mitochondrial function and increase frataxin levels in a cellular model of Friedreich's ataxia., 26 (12): [PMID:29773347] [10.1016/j.bmc.2018.05.005] |
2. Khdour OM, Bandyopadhyay I, Visavadiya NP, Roy Chowdhury S, Hecht SM.. (2018) Phenothiazine antioxidants increase mitochondrial biogenesis and frataxin levels in Friedreich's ataxia cells., 9 (9): [PMID:30288223] [10.1039/C8MD00274F] |
3. Liu J,Bandyopadhyay I,Zheng L,Khdour OM,Hecht SM. (2020) Antiferroptotic Activity of Phenothiazine Analogues: A Novel Therapeutic Strategy for Oxidative Stress Related Disease., 11 (11): [PMID:33214825] [10.1021/acsmedchemlett.0c00293] |
Source(1):